North America Beta-Glucan Market Report by Source, Product, Application, Countries and Companies Analysis 2026-2034

North America Beta Glucan Market Size & Forecast 2026-2034

North America Beta Glucan Market is projected to grow from US$ 218.23 million in 2025 to US$ 399.86 Million by 2034, registering a CAGR of 6.96% during the forecast period from 2026 to 2034. Market growth is being driven by increasing consumer awareness of immune health, rising demand for functional foods and dietary supplements, and expanding applications in pharmaceuticals and personal care products. Growing interest in natural ingredients, coupled with advancements in extraction technologies and product innovation, is expected to further support market expansion across the region throughout the forecast period.

North America Beta Glucan Market Outlooks

Beta glucan is a naturally occurring soluble fiber found in the cell walls of oats, barley, yeast, mushrooms, and certain bacteria. It is widely recognized for its health-promoting properties, particularly its ability to support immune function, improve heart health, and help regulate blood cholesterol and blood sugar levels. Due to these benefits, beta glucan has become a popular ingredient in dietary supplements, functional foods, beverages, and pharmaceutical products.

In North America, the popularity of beta glucan has increased significantly as consumers become more health-conscious and seek natural ingredients that support overall wellness. The growing prevalence of lifestyle-related conditions such as obesity, diabetes, and cardiovascular diseases has further boosted demand for products containing beta glucan. Food manufacturers are increasingly incorporating oat- and barley-derived beta glucan into cereals, bakery products, dairy alternatives, and nutritional beverages to enhance their health appeal. Additionally, the expanding nutraceutical industry and rising interest in immune-support supplements have contributed to market growth. Strong consumer awareness, scientific validation of health benefits, and a well-developed functional food sector continue to make North America one of the leading markets for beta glucan-based products.

Beta Glucan-related Product launches and Commercial Introductions in North America

Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States

• Cardiovascular disease (CVD), listed as the underlying cause of death, accounted for 941 652 deaths in the United States in 2022.
• Heart disease and stroke claimed more lives in 2022 in the United States than all forms of cancer and chronic lower respiratory disease combined.
• Between 2017 and 2020, 127.9 million US adults (48.6%) had some form of CVD. Between 2020 and 2021, direct and indirect costs of total CVD were $417.9 billion ($233.3 billion in direct costs and $184.6 billion in indirect costs/mortality).
• In 2017 to 2020 in the United States, 59.0% of non-Hispanic Black females and 58.9% of non-Hispanic Black males had some form of CVD. This race category had the highest prevalence of CVD.
• In 2022 in the United States, coronary heart disease (CHD) was the leading cause of deaths (39.5%) attributable to CVD in the United States, followed by stroke (17.6%), other CVD (17.0%), hypertensive diseases (14.0%), heart failure (9.3%), and diseases of the arteries (2.6%).
• Direct costs for CVD accounted for 11% of total US health expenditures in 2020 to 2021, more than any major diagnostic group except diseases of the musculoskeletal system.
• CVD accounted for approximately 19.41 million global deaths in 2021.

North America Beta Glucan Market Growth Drivers

Rising Consumer Demand for Functional Foods and Preventive Healthcare

One of the primary growth drivers of the North America beta glucan market is the increasing consumer focus on preventive healthcare and functional nutrition. Consumers are becoming more proactive in managing their health through dietary choices, driving demand for ingredients that offer scientifically supported health benefits. Beta glucan is widely recognized for its ability to support heart health, strengthen immunity, improve digestive function, and help regulate cholesterol levels. As a result, food and beverage manufacturers are incorporating beta glucan into cereals, bakery products, dairy alternatives, snacks, and nutritional beverages. The growing prevalence of lifestyle-related diseases such as obesity, diabetes, and cardiovascular disorders has further accelerated interest in health-promoting ingredients. In addition, aging populations across North America are seeking products that support long-term wellness and healthy aging. This shift toward preventive healthcare and nutritional self-care continues to create substantial opportunities for beta glucan manufacturers and suppliers throughout the region. BENEO introduced barley beta-glucans in July 2023 to grow its Fiber Portfolio, providing benefits to heart health and blood sugar control. The new Orafti β-Fit was featured at the IFT Food Expo in Chicago.

Expansion of the Nutraceutical and Dietary Supplement Industry

The rapid growth of the nutraceutical and dietary supplement industry is significantly contributing to the expansion of the North America beta glucan market. Consumers are increasingly turning to supplements that enhance immunity, improve overall health, and reduce the risk of chronic illnesses. Beta glucan has gained widespread acceptance in this sector due to its immune-modulating properties and its natural origin. The ingredient is commonly used in capsules, tablets, powders, and liquid formulations targeting immune support and wellness. Growing awareness of the relationship between nutrition and immune health, particularly following recent global health concerns, has increased demand for evidence-based supplement ingredients. Manufacturers are also investing in innovative delivery formats and premium formulations containing beta glucan derived from oats, barley, yeast, and mushrooms. The strong presence of established supplement brands, combined with rising consumer spending on health and wellness products, continues to strengthen market growth across North America. Feb 2025, Layn Natural Ingredients has opened a more extensive biotechnology plant to specialize in precision fermentation and enzyme-based technology. This plant will maximize large-scale production of eco-friendly bioactive ingredients, further increasing Layn's efficiency and sustainability in manufacturing pure ingredients.

Technological Advancements and Product Innovation

Advancements in extraction technologies and product development are playing a vital role in driving the North America beta glucan market. Manufacturers are investing in research and innovation to improve the purity, functionality, and bioavailability of beta glucan ingredients. These technological improvements allow beta glucan to be incorporated into a broader range of food, beverage, pharmaceutical, and personal care products without compromising taste, texture, or product stability. New formulations are enabling manufacturers to develop innovative products that cater to evolving consumer preferences for clean-label, plant-based, and natural ingredients. In addition, scientific studies supporting the health benefits of beta glucan continue to enhance consumer confidence and encourage product adoption. The growing availability of customized beta glucan solutions tailored to specific applications is helping companies differentiate their offerings in competitive markets. As innovation continues to expand application possibilities, demand for beta glucan is expected to increase steadily across multiple industries. June 2024: Cargill's barley beta-glucan concentrate will gain new health claim approval from the U.S. Food and Drug Administration (FDA), associating the ingredient with a lower risk of heart disease.

North America Beta Glucan Market Challenges

High Production Costs and Complex Extraction Processes

One of the major challenges facing the North America beta glucan market is the relatively high cost associated with production and extraction. Obtaining high-purity beta glucan from sources such as oats, barley, yeast, and mushrooms requires advanced processing technologies and strict quality control measures. These extraction processes can be resource-intensive, increasing manufacturing expenses and limiting profitability for some producers. In addition, maintaining consistent product quality and biological activity across batches presents technical challenges. The higher production costs are often passed on to consumers, making beta glucan-enriched products more expensive than conventional alternatives. This pricing gap can limit adoption among price-sensitive consumers, particularly during periods of economic uncertainty. Smaller manufacturers may also face barriers to entry due to the significant capital investment required for production infrastructure, research, and regulatory compliance. These factors collectively present challenges to broader market penetration and expansion.

Limited Consumer Awareness and Market Education Gaps

Despite growing interest in functional ingredients, consumer awareness regarding the specific benefits of beta glucan remains relatively limited compared with more widely recognized health ingredients such as probiotics, protein, or omega-3 fatty acids. Many consumers are unfamiliar with the different sources of beta glucan and may not fully understand its role in supporting immunity, cardiovascular health, and digestive wellness. This knowledge gap can reduce purchasing intent and slow market growth. Additionally, varying product labels and health claims across brands can create confusion among consumers regarding efficacy and product quality. Manufacturers must invest significantly in educational campaigns, marketing initiatives, and scientific communication to build awareness and trust. Healthcare professionals and nutrition experts also play an important role in influencing consumer understanding and adoption. Without continued efforts to improve market education and communicate the proven health benefits of beta glucan, the industry may face challenges in reaching its full growth potential across North America.

North America Cereal Beta Glucan Market

Cereal-derived beta glucan, primarily sourced from oats and barley, represents the largest segment of the North American beta glucan market. Its scientifically recognized benefits for cardiovascular health and cholesterol management have made it a preferred ingredient in breakfast cereals, bakery products, nutritional supplements, and functional foods. As consumers increasingly seek fiber-rich and clean-label products, manufacturers are incorporating cereal beta glucan into a wide range of formulations. Its ability to support digestive health and overall wellness continues to strengthen demand across both food and nutraceutical applications.

North America Mushroom Beta Glucan Market

Mushroom-derived beta glucan is gaining significant traction across North America due to its association with immune system support and natural wellness. Extracted from varieties such as reishi, shiitake, maitake, and lion’s mane mushrooms, it is widely used in dietary supplements, functional beverages, and wellness products. The growing popularity of medicinal mushrooms and holistic healthcare approaches has accelerated consumer interest, positioning mushroom beta glucan as an important ingredient in the region’s expanding nutraceutical industry.

North America Soluble Beta Glucan Market

The soluble beta glucan segment is experiencing robust growth in North America as food and beverage manufacturers seek highly functional ingredients with proven health benefits. Soluble beta glucan offers excellent dispersibility and bioavailability, making it suitable for incorporation into beverages, meal replacements, protein bars, and nutritional products. Consumers are increasingly attracted to products that support heart health, digestive wellness, and blood sugar management, creating strong demand for soluble beta glucan-based formulations across multiple end-use industries.

North America Pharmaceuticals Beta Glucan Market

The pharmaceutical sector in North America is increasingly exploring the therapeutic potential of beta glucan due to its immune-enhancing and anti-inflammatory properties. Research has highlighted its potential applications in immune health, oncology support, infection management, and wound care. Pharmaceutical companies are investing in studies and product development initiatives aimed at leveraging beta glucan’s biological activities. As demand for innovative and naturally derived healthcare ingredients grows, the pharmaceutical application of beta glucan is expected to expand steadily throughout the forecast period.

North America Food & Beverages Beta Glucan Market

Beta glucan has become a valuable functional ingredient in the North American food and beverage industry. Its natural fiber content and health-supporting characteristics make it an attractive addition to cereals, dairy products, snack bars, plant-based foods, and functional beverages. Manufacturers are increasingly utilizing beta glucan to enhance nutritional profiles and meet consumer demand for wellness-focused products. The trend toward preventive healthcare and healthier eating habits continues to support the ingredient’s widespread adoption across diverse food categories.

United States Beta Glucan Market

The United States accounts for the largest share of the North American beta glucan market, driven by strong consumer demand for functional foods, dietary supplements, and immune-support products. Growing awareness of cardiovascular health, digestive wellness, and preventive nutrition has encouraged the adoption of beta glucan-enriched products. The country also serves as a major hub for research, innovation, and product development, with manufacturers continuously introducing new applications in food, pharmaceuticals, and personal care. Rising consumer interest in immunity-focused nutrition and scientifically validated ingredients is expected to sustain market growth in the coming years.  As 73% of US consumers are looking for foods that boost the immune system, the market is expected to reach USD 96.5 billion by 2023. Oat products with beta-glucans saw their retail sales jump by 42% between 2021 and 2023, fueled by the FDA's health claim and a 56% increase in beta-glucan launches.

Canada Beta Glucan Market

Canada’s beta glucan market is witnessing consistent expansion, supported by increasing consumer awareness of nutrition and preventive healthcare. Oat-based products remain particularly popular, contributing significantly to demand for cereal-derived beta glucan. The country’s strong focus on dietary fiber intake and cardiovascular wellness has encouraged food manufacturers and supplement producers to incorporate beta glucan into a growing range of products. Favorable regulatory support, research initiatives, and investments in agricultural innovation are further strengthening domestic production capabilities and market development. Supportive regulations and financing, such as CAD 350 million in the 2023 Regulatory Innovation Agenda and CAD 28.5 million for beta-glucan research, are fueling market expansion. Health Canada approved approximately 2,500 beta-glucan products between 2021 and 2023, and the CFIA accelerated approvals, leading to a 62% increase in registrations. The CAD 175 million investment by the AgriInnovate Program for 2024-2027 has boosted domestic beta-glucan production capacity by 34% in 2023.

Mexico Beta Glucan Market

Mexico is emerging as a promising market for beta glucan, driven by rising health awareness and growing concern over chronic lifestyle-related diseases. Food and beverage companies are increasingly introducing products fortified with beta glucan to address consumer demand for functional nutrition and immune support. Although market penetration remains lower than in the United States and Canada, educational campaigns promoting healthy lifestyles and nutritional awareness are expanding consumer acceptance. Urbanization, improving purchasing power, and increasing interest in preventive health solutions are expected to support future market growth across the country.

North America Beta-Glucan Market Segments

Source

• Cereal
• Mushroom
• Yeast
• Seaweed

Product

• Soluble
• Insoluble

Application

• Food & Beverages
• Pharmaceuticals
• Cosmetics & Personal Care
• Animal Feed
• Others

Countries

• United States
• Canada
• Mexico
• Rest of North America

Companies have been covered from 5 viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Koninklijke Philips N.V.
• EDAP TMS S.A
• Johnson & Johnson
• Medtronic Plc.
• Hitachi Ltd.
• Theraclion
• Stryker
• General Electrics

Report Details: